Search Sort by Newest to OldestOldest to NewestRelevanceA-ZZ-A Optimizing 340B Participation Compliantly While “Waiting and Watching” New Developments Hospitals and health systems that participate in the federal 340B Drug Pricing Program are currently facing challenges on multiple fronts, including manufacturer restrictions and program audits, legal challenges, and constantly-evolving federal and state requirements for participation. Article 2023 State of Healthcare Performance Improvement Report: Signs of Stabilization Emerge Hospitals and health systems are seeing some signs of stabilization in 2023 following an extremely difficult year in 2022. Workforce-related challenges persist, however, keeping costs high and contributing to issues with patient access to care. Research Report
Optimizing 340B Participation Compliantly While “Waiting and Watching” New Developments Hospitals and health systems that participate in the federal 340B Drug Pricing Program are currently facing challenges on multiple fronts, including manufacturer restrictions and program audits, legal challenges, and constantly-evolving federal and state requirements for participation. Article
2023 State of Healthcare Performance Improvement Report: Signs of Stabilization Emerge Hospitals and health systems are seeing some signs of stabilization in 2023 following an extremely difficult year in 2022. Workforce-related challenges persist, however, keeping costs high and contributing to issues with patient access to care. Research Report